NIH launches possible COVID treatment by using monoclonal antibodies

U.S. pharmaceutical company Eli Lilly is collaborating with the National Institutes of Health on a lab-engineered treatment called monoclonal antibodies to stop the virus from spreading in the body. Dr. Jon LaPook has the latest in CBS News’ “Racing to a Cure” series. Source